PUBLISHED DATE : Feb 2023 | Pages : 291
Fill out your details & get your free sample
The Global Therapeutic Contact Lenses Market Size, Share, and Growth Forecast by:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
291 Pages
135 Tables
114 Charts
5 Regions
19 Countries
20 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 4.25 Billion |
| Market Size (2021) | USD 3.19 Billion |
| CAGR (2021-2027) | 4.90% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Material, Usage, Application, Distribution Channel, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Alcon, Bausch & Lomb, Johnson & Johnson, and The Cooper Companies |
The global therapeutic contact lenses market was valued at USD 3.19 billion in 2021 and is expected to reach USD 4.25 billion by 2027, growing at a CAGR of 4.90%. The increasing awareness about the advantages of therapeutic contact lenses over traditional eyeglasses and the sudden surge in the penetration of contact lenses among working professionals and youth are majorly contributing to the market growth.
Therapeutic contact lenses (TCLs) are mainly used for corneal diseases, and the clinical use of TCL after ophthalmic surgery usually focuses on corneal lesions, corneal refractive surgery, and corneal transplantation. These bandages were also used in cataract surgery. It also stimulates corneal metabolism, improves corneal regeneration, increases epithelial adhesion, maintains hydration, reduces collagenase accumulation, reduces edema, improves corneal clarity and vision, and is a vehicle for ophthalmic drug delivery.
The two most common contact lens variants available in the therapeutic contact lenses market include hard and soft contact lenses. RGP contact lenses are the most common type of hard contact lenses available in the industry. These lenses are usually made from plastic materials. These lenses hold their shape firmly and allow oxygen to flow through the wearer’s eye lens. RGP lenses are helpful for people with astigmatism and keratoconus as they enable sharper vision when the cornea is unevenly curved compared to soft contact lenses. Soft contact lenses are made up of hydrogel and silicone hydrogel materials.
Nearly 125 million people worldwide wear contact lenses to correct regular or common vision problems, such as myopia, hyperopia, presbyopia, and astigmatism. This vision correction can be done per the user's needs without disturbing the physical appearance. By 2050, more than 2 billion people will be aged over 60. There is an increase in the global target population with the number of people requiring vision corrections. For instance, around 153 million people are affected by uncorrected refractive errors, 1.7 billion have presbyopia, 352 million people suffer from dry eyes, and 20 million people are facing blind from cataracts. In addition, the diabetic population does suffer from various vision-related issues. For instance, around 93 million people suffer from diabetic retinopathy, and more than 67 million suffer from glaucoma.
The advent of new technologies and materials has greatly increased the clinical use of contact lenses to treat ocular surface disorders. Soft therapeutic contact lenses are a popular option for treating corneal defects and offer the added benefit of improved vision. Continued manufacturing and application innovation could expand the therapeutic contact lenses market role, leading to improved patient outcomes.
IMPACT OF COVID-19
The COVID-19 pandemic has largely affected customer behavior regarding therapeutic contact lenses. A considerable rise in first-time contact lens users has recently been witnessed. However, there has been an increase in the market's percentage of contact lens dropouts. Some first-time contact lens users include medical professionals, management professionals, and office workers who use computers and electronic devices for long hours daily. The common goal of these contact lens users was to eliminate the dependency on spectacle corrections while performing critical tasks. Simultaneously, in 2020, there was an increase in dropouts among long-term contact lens users in the therapeutic contact lenses market. Some reasons for a decline or complete discontinuation in contact lenses include concerns associated with the high risk of contracting infections, worsened dry eye conditions, and low demand for contact lenses due to remote work options from the comfort of homes.
Increasing Use of Silicone Hydrogel Contact Lenses
Silicone hydrogel contact lenses have become the most widely used contact lenses. As they are easy and handy to use with no maintenance required, they do not cause any harm to people compared to extended wearable lenses. Also, Silicone hydrogel lenses can treat eye problems such as red eyes, blurred vision, corneal swelling, and general discomfort in the eyes. Many key players in the therapeutic contact lenses market do offer Silicone hydrogel therapeutic contact lenses, such as Acuvue Oasys (Johnson & Johnson Vision Care), Air Optix Aqua (Alcon), Biofinity (CooperVision), and PureVision2 (Bausch & Lomb).
The Coming Rise of Drug-delivery Contact Lenses
Extensive research has been documented recognizing the potential of BCL as a drug delivery system. This is due to their superior drug bioavailability compared to eye drops and their ability to be used on long-wearing schedules, increasing dosing frequency, side effects, and compliance. Desired properties of drug delivery devices include easy, comfortable, and controlled administration over an extended period with preservation of vision and ocular function.
Introduction of Hi-Tech Contact Lenses
Hi-tech contact lenses are used to treat eye disorders and more. The hi-tech contact lenses involve various processes, such as delivering the drug to the eye, providing augmented reality, monitoring eye health conditions, and more. Mojo Vision, a California-based company working on AR (Augmented Reality) based smart contact lenses, has launched contact lenses that elevate users' vision. These lenses are equipped with an inbuilt display that provides timely information regarding the objects focused on without interrupting the real vision.
Growing Prevalence of Ophthalmic Disorders & Geriatric Population
As populations continue to expand, so does the need for eye care. Aging is one of the most significant global demographic factors impacting eye care as the need for vision correction increases and becomes more complex as a person grows older. In 2018, around one-third of the global population was above the age of 45, the average onset of presbyopia (long-sightedness caused by loss of elasticity of the eye's lens).
Further, the rise in urbanization and the expansion of middle classes in fast-developing markets, particularly in Latin America and Asia, have transformed the economy and local eye health requirements. A considerable increase in migration from rural areas to cities in search of better jobs has contributed to the demand for better healthcare requirements and trends. Increased disposable incomes are encouraging people to prefer the luxury products like contact lenses in the market, which is one of the major factors contributing to the growth of the global therapeutic contact lenses market.
Technological Advancements in Contact Lenses
The key vendors in the contact lenses market are constantly investing in research & development to launch a new variety of contact lenses benefitting the market's users and fulfilling the market's unmet needs. New products are one of the unique strategies to drive customers towards new products with unique features in the therapeutic contact lenses market. In 2019, Bausch & Lomb launched the ULTRA multifocal toric contact lens for presbyopia patients. The ULTRA multifocal for astigmatism features vision at all distances and a stable fit for consistent results.
Public and Private Initiatives to Increase Vision Care Awareness
Favorable initiatives of governments around the world to promote advanced vision aids will support therapeutic contact lenses market growth in the coming years. For example, the US Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) is actively working to raise awareness of behaviors and risk factors that affect vision in contact lens wearers through the Vision Health Initiative. In addition to government and public health organizations, many private organizations worldwide are actively involved in advancing ophthalmology. For example, in 2018, Johnson & Johnson Vision launched a global campaign called SpotlightSight in honor of World Sight Day.
INSIGHTS BY MATERIAL
The global therapeutic contact lenses market is segmented into soft and rigid contact lenses by material segment. Among the material segment, the soft contact lenses segment dominates the market with a share of 85.25%, followed by rigid contact lenses in 2021. The soft contact lenses segment will likely witness the highest CAGR of 5.03%, with incremental growth of USD 932.18 million. Hydrogels used to manufacture therapeutic soft contact lenses are commonly synthesized by free radical and UV photopolymerization and cast molding. The main network of hydrogels that make up soft contact lenses is usually based on poly(hydroxyethyl methacrylate) (HEMA), especially methafilcon A. Soft hydrogel contact lenses are typically more comfortable to wear than rigid or hard lenses, as they are more flexible and move and bend with the eyes.
INSIGHTS BY USAGE
The daily replacement segment dominated the global therapeutic contact lenses market, with a share of 55.24% in 2021, and is likely to witness the highest CAGR of 5.16%. Daily replacement contact lenses are one-time usable lenses that are discarded post-usage. One of the major reasons for the preference is its ease of use, reduced infections, and more comfort on the eye. This has largely driven the usage of daily disposable contact lenses in the market. Daily disposable contact lenses are increasing among specialists and are also largely recommended among users. Further, the adoption of daily contact lenses is high among developed countries, whereas among developing countries, the usage of daily disposable contact lenses is low in the market.
INSIGHTS BY APPLICATION
The post-ocular surgery segment dominated the global therapeutic contact lenses market with a share of 35.77%. The use of therapeutic lenses is safe and effective in protecting the ocular surface and stabilizing the tear film after cataract surgery, has the advantage of preserving the 'immediate vision' of the operated eye, and is a promising alternative to covering the eye patch coverage in the postoperative management of cataracts surgical patients, especially those with monovision.
However, the corneal surgery/disorder segment will likely witness the highest incremental growth of USD 345.57 million over the forecast period. Therapeutic contact lenses are important for treating ocular surface and corneal disorders. A therapeutic contact lens or bandage lens is a contact lens that protects and heals the cornea. Further, the increasing number of corneal surgeries drives the demand for therapeutic lenses. Corneal surgery/transplantation is currently the world's most widely performed tissue transplant procedure.
INSIGHTS BY DISTRIBUTION CHANNEL
The Omni channel distribution dominates the therapeutic contact lenses market with a share of 73.31%. It is likely to witness incremental growth of USD 864.79 million. The Omni channels comprise retail and online stores. Compared to developed countries, such as Latin America and Asia, distribution through retail stores has increased in developing countries. The reputation, consumer awareness about the brands, and customer satisfaction have increased loyalty, still driving them to prefer retail stores to purchase contact lenses in the market. In addition, multiple commercial campaigns are launched by various retail stores, which attracts users to move towards retail stores.
In 2021, North America dominated the global therapeutic contact lenses market with a share of 34.68%. The region is one of the major consumers of contact lenses due to people's increased awareness and disposable income. This makes the companies largely focus on launching their products in the market. Countries like the US and Canada have well-developed healthcare systems and a stringent regulatory environment for manufacturers of contact lenses. Also, market vendors are investing in R&D initiatives and advanced technologies to develop efficient contact lens products.
APAC is expected to witness the highest CAGR growth of 5.30% in the global therapeutic contact lenses market over the forecast period. In 2020, APAC had a higher number of customers using contact lenses in the countries such as China, India, and more. In addition, the surge in the target population is majorly driving the demand for contact lenses. The growing myopic population in the region, including teenagers, and elderly individuals, is one of the driving factors. In addition, increasing awareness regarding brand consciousness is accelerating the demand for contact lenses in the region.
In 2021, the European therapeutic contact lenses market was valued at USD 721.88 million. In 2020, Europe emerged as one of the largest regions for contact lenses and solutions. Factors such as changing buyer preferences and rising inclination toward cosmetic lenses drive the market. Also, the surge in sports or physical activities and theatrical performances has resulted in a rise in demand for cosmetic and color lenses. Therefore, several players are launching advanced contact lenses in the European market. Local and global players in the market largely dominate the Europe therapeutic contact lenses market.
The global therapeutic contact lenses market is highly consolidated, with the key players including Alcon, Bausch & Lomb, Johnson & Johnson, and The Cooper Companies accounting for a major market share. The market is subjected to constant technological advances and regularly evolving vision correction requirements and standards. Vendors compete based on product variety, pricing, quality, technological leadership and innovation, and the efficacy of therapeutic contact lenses.
Key Developments in The Global Therapeutic Contact Lenses Market
Frequently Asked Questions
What is the size of the therapeutic contact lenses market?
The global therapeutic contact lenses market is projected to reach USD 4.25 billion in 2027 from USD 3.19 billion in 2021.
What is the growth rate of the therapeutic contact lenses market?
The global therapeutic contact lenses market is expected to grow at a CAGR of 4.90% from 2021 to 2027.
Who are the key players in the global therapeutic contact lenses market?
The leading players in the global therapeutic contact lenses market are Alcon, Bausch & Lomb, Johnson & Johnson, and The Cooper Companies.
Which region has the highest global therapeutic contact lenses market share?
North America holds the highest global therapeutic contact lenses market share at 34.68%. The region is one of the major consumers of contact lenses due to people's increased awareness and disposable income.
What factors impact the growth of the therapeutic contact lenses market?
The increasing use of silicone hydrogel contact lenses, the rise of drug-delivery contact lenses, and the introduction of hi-tech contact lenses are the key factors impacting the global therapeutic contact lenses market.
The therapeutic contact lenses market is expected to grow at a CAGR of approximately 4.90% from 2021 to 2027.
The following factors are likely to contribute to the growth of the global therapeutic contact lenses market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the global therapeutic contact lenses market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Material
Segmentation by Usage
Segmentation By Application
Segmentation By Distribution Channel
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY MATERIAL
4.3.2 MARKET SEGMENTATION BY USAGE
4.3.3 MARKET SEGMENTATION BY APPLICATION
4.3.4 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASE IN SILICONE HYDROGEL CONTACT LENSES APPLICATION
9.2 ADVANCES IN DRUG-DELIVERY CONTACT LENSES TECHNOLOGY
9.3 INTRODUCTION OF HI-TECH CONTACT LENSES
10 MARKET GROWTH ENABLERS
10.1 GROWING PREVALENCE OF OPHTHALMIC DISORDERS & GERIATRIC POPULATION
10.2 ADVANCES IN CONTACT LENSES TECHNOLOGY
10.3 PUBLIC AND PRIVATE INITIATIVES TO INCREASE VISION CARE AWARENESS
11 MARKET RESTRAINTS
11.1 HIGH COST OF THERAPEUTIC CONTACT LENSES
11.2 ADVERSE EVENTS ASSOCIATED WITH CONTACT LENSES
11.3 LOW ACCESSIBILITY, AFFORDABILITY, & FINANCIAL EXCLUSION FOR LARGE PATIENT POOL
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 GEOGRAPHY INSIGHTS
12.2.2 MATERIAL SEGMENTATION INSIGHTS
12.2.3 USAGE SEGMENTATION INSIGHTS
12.2.4 APPLICATIONS SEGMENTATION INSIGHTS
12.2.5 DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 MATERIAL
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SOFT CONTACT LENSES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 SOFT CONTACT LENSES MARKET BY GEOGRAPHY
13.4 RIGID CONTACT LENSES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 RIGID CONTACT LENSES MARKET BY GEOGRAPHY
14 USAGE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 DAILY REPLACEMENT
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 DAILY REPLACEMENT MARKET BY GEOGRAPHY
14.4 FREQUENT REPLACEMENT
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 FREQUENT REPLACEMENT MARKET BY GEOGRAPHY
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 POST OCULAR SURGERY
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 POST OCULAR SURGERY MARKET BY GEOGRAPHY
15.4 CORNEAL SURGERY/DISORDER
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 CORNEAL SURGERY/DISORDER MARKET BY GEOGRAPHY
15.5 DRUG DELIVERY
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
16 DISTRIBUTION CHANNEL
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 OMNI CHANNEL
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
16.4 HOSPITALS & EYE CARE CLINICS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 NORTH AMERICA MARKET BY MATERIAL
18.2.2 NORTH AMERICA MARKET BY USAGE
18.2.3 NORTH AMERICA MARKET BY APPLICATION
18.2.4 NORTH AMERICA MARKET BY DISTRIBUTION CHANNEL
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
19.2.2 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE
19.2.3 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
19.2.4 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
19.3 KEY COUNTRIES
19.3.1 JAPAN: MARKET SIZE & FORECAST
19.3.2 CHINA: MARKET SIZE & FORECAST
19.3.3 INDIA: MARKET SIZE & FORECAST
19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.3.5 AUSTRALIA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
20.2.2 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE
20.2.3 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
20.2.4 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
20.3 KEY COUNTRIES
20.3.1 GERMANY: MARKET SIZE & FORECAST
20.3.2 FRANCE: MARKET SIZE & FORECAST
20.3.3 UK: MARKET SIZE & FORECAST
20.3.4 SPAIN: MARKET SIZE & FORECAST
20.3.5 ITALY: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
21.2.2 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE
21.2.3 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
21.2.4 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
22.2.2 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE
22.2.3 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
22.2.4 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
22.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.4 UAE: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 ALCON
23.2.2 BAUSCH & LOMB
23.2.3 JOHNSON & JOHNSON
23.2.4 THE COOPER COMPANIES
24 KEY COMPANY PROFILES
24.1 ALCON
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 BAUSCH & LOMB
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 JOHNSON & JOHNSON
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 THE COOPER COMPANIES
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERING
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ABB OPTICAL GROUP
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ACCULENS
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 ADVANCED VISION TECHNOLOGIES
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 CONTAMAC
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 EXCELLENT HI-CARE
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 MEDENNIUM
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 MENICON
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 METRO OPTICS
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 ORION VISION GROUP
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 POLYTOUCH
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 ST. SHINE OPTICAL
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 SURGITECH INNOVATION
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 SYNEREYES
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 ULTRAVISION CLPL
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 WALMAN
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 VISIONARY OPTICS
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY MATERIAL
27.3 MARKET BY USAGE
27.4 MARKET BY APPLICATION
27.5 MARKET BY DISTRIBUTION CHANNEL
27.6 NORTH AMERICA: BY MATERIAL
27.7 NORTH AMERICA: BY USAGE
27.8 NORTH AMERICA: BY APPLICATION
27.9 NORTH AMERICA: BY DISTRIBUTION CHANNEL
27.1 APAC: BY MATERIAL
27.11 APAC: BY USAGE
27.12 APAC: BY APPLICATION
27.13 APAC: BY DISTRIBUTION CHANNEL
27.14 EUROPE: BY MATERIAL
27.15 EUROPE: BY USAGE
27.16 EUROPE: BY APPLICATION
27.17 EUROPE: BY DISTRIBUTION CHANNEL
27.18 LATIN AMERICA: BY MATERIAL
27.19 LATIN AMERICA: BY USAGE
27.2 LATIN AMERICA: BY APPLICATION
27.21 LATIN AMERICA: BY DISTRIBUTION CHANNEL
27.22 MIDDLE EAST & AFRICA: BY MATERIAL
27.23 MIDDLE EAST & AFRICA: BY USAGE
27.24 MIDDLE EAST & AFRICA: BY APPLICATION
27.25 MIDDLE EAST & AFRICA: BY DISTRIBUTION CHANNEL
28 APPENDIX
28.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL THERAPEUTIC CONTACT LENSES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF INCREASE IN SILICONE HYDROGEL CONTACT LENSES APPLICATION
EXHIBIT 4 IMPACT OF ADVANCES IN DRUG-DELIVERY CONTACT LENSES TECHNOLOGY
EXHIBIT 5 IMPACT OF INTRODUCTION OF HI- TECH CONTACT LENSES
EXHIBIT 6 IMPACT OF GROWING PREVALENCE OF OPHTHALMIC DISORDERS & GERIATRIC POPULATION
EXHIBIT 7 IMPACT OF ADVANCES IN CONTACT LENSES TECHNOLOGY
EXHIBIT 8 IMPACT OF PUBLIC AND PRIVATE INITIATIVES TO INCREASE VISION CARE AWARENESS
EXHIBIT 9 IMPACT OF HIGH COST OF THERAPEUTIC CONTACT LENSES
EXHIBIT 10 IMPACT OF ADVERSE EVENTS ASSOCIATED WITH CONTACT LENSES
EXHIBIT 11 IMPACT OF LOW ACCESSIBILITY, AFFORDABILITY & FINANCIAL EXCLUSION FOR LARGE PATIENT POOL
EXHIBIT 12 NUMBER OF PEOPLE WITH TREATED & UNTREATED VISION IMPAIRMENTS WORLDWIDE (BILLION)
EXHIBIT 13 NUMBER OF OPHTHALMOLOGISTS PER MILLION POPULATION 2019
EXHIBIT 14 EYE CARE PRACTICES WITNESSING MARKET CHANGES
EXHIBIT 15 GLOBAL THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 16 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027 (%)
EXHIBIT 17 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: MARKET SHARE 2021 & 2027 (%)
EXHIBIT 18 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: MARKET SHARE 2021 & 2027 (%)
EXHIBIT 19 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: MARKET SHARE 2021 & 2027 (%)
EXHIBIT 20 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: MARKET SHARE 2021 & 2027 (%)
EXHIBIT 21 FIVE FORCES ANALYSIS 2021
EXHIBIT 22 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 23 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: INCREMENTAL GROWTH
EXHIBIT 24 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: ABSOLUTE GROWTH
EXHIBIT 25 GLOBAL SOFT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 26 GLOBAL SOFT THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 27 GLOBAL RIGID THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 GLOBAL RIGID THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 29 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 30 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: INCREMENTAL GROWTH
EXHIBIT 31 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 GLOBAL FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 37 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 38 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 41 GLOBAL CORNEAL SURGERY/DISORDERS THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL CORNEAL SURGERY/DISORDERS THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 GLOBAL DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 45 GLOBAL OTHER THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL OTHER THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 48 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH
EXHIBIT 49 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 52 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY HOSPITAL & EYE CARE CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 55 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 56 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 57 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 58 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
EXHIBIT 59 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY NORTH AMERICA 2021 & 2027
EXHIBIT 61 US POPULATION SUFFERING FROM VISION DISORDERS (MILLION)
EXHIBIT 62 US THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 63 CANADA THERAPEUTIC CONTACT LENSES MARKET 2021–2027($ MILLION)
EXHIBIT 64 APAC THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 65 APAC THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
EXHIBIT 66 HISTORICAL DATA OF CONTACT LENSES USAGE IN APAC 2018–2020 ($ MILLION)
EXHIBIT 67 APAC THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY APAC 2021 & 2027
EXHIBIT 69 JAPAN THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 70 CHINA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 71 INDIA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 72 SOUTH KOREA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 73 AUSTRALIA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 74 EUROPE THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 EUROPE THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES (2021)
EXHIBIT 76 HISTORICAL DATA OF CONTACT LENSES USAGE IN EUROPE 2018–2020 ($ MILLION)
EXHIBIT 77 EUROPE THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY EUROPE 2021 & 2027
EXHIBIT 79 GERMANY THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 80 FRANCE THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 81 UK THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 82 SPAIN THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 83 ITALY THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 84 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 85 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
EXHIBIT 86 LATIN AMERICA CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH BY LATIN AMERICA 2021 & 2027
EXHIBIT 88 BRAZIL THERAPEUTIC CONTACT LENSES MARKET IN COUNTRY 2021–2027 ($ MILLION)
EXHIBIT 89 MEXICO THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 ARGENTINA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 91 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 92 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
EXHIBIT 93 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 94 INCREMENTAL GROWTH BY MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 95 TURKEY THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 96 SOUTH AFRICA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 SAUDI ARABIA THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 98 UAE THERAPEUTIC CONTACT LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 99 PURE & DIVERSIFIED VENDORS IN GLOBAL THERAPEUTIC CONTACT LENSES MARKET
EXHIBIT 100 VENDORS OFFERING COMMERCIAL THERAPEUTIC CONTACT LENSES: MARKET DOMINANCE ANALYSIS
EXHIBIT 101 VENDORS OFFERING COMMERCIAL THERAPEUTIC CONTACT LENSES: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 102 ALCON: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 103 ALCON: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 104 ALCON: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 105 ALCON: REVENUE BY GEOGRAPHY 2019–2021 ($ MILLION)
EXHIBIT 106 BAUSCH & LOMB: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 107 JOHNSON & JOHNSON: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 108 JOHNSON & JOHNSON: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 109 JOHNSON & JOHNSON: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 110 JOHNSON & JOHNSON: MAJOR PRODUCT OFFERINGS
EXHIBIT 111 THE COOPER COMPANIES: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 112 THE COOPER COMPANIES: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 113 THE COOPER COMPANIES: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 RECENT HI-TECH CONTACT LENSES
TABLE 4 GLOBAL AGE COMPOSITION (2020)
TABLE 5 ADVANTAGES & DISADVANTAGES OF HYDROGEL CONTACT LENSES
TABLE 6 SOFT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 7 SOFT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 8 RIGID THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 9 RIGID THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 10 DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 11 DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 12 FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 13 FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 14 POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 15 POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 16 CORNEAL SURGERY/DISORDER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 17 CORNEAL SURGERY/DISORDER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 18 ADVANTAGES & DISADVANTAGES OF MAIN METHODOLOGIES USED PREPARE DRUG-LOADED CONTACT LENSES
TABLE 19 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 20 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 21 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 22 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 23 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 24 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 25 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 26 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 27 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 28 NORTH AMERICA CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 29 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 30 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 31 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 32 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 33 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 34 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 35 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 36 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 37 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 38 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 39 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 40 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 41 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 42 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 43 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 44 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 45 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 46 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 47 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 48 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 49 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 50 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 51 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 52 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 53 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 54 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 55 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 56 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 57 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 58 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 59 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 60 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 61 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 62 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 63 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 65 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 66 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 67 ALCON: MAJOR PRODUCT OFFERINGS
TABLE 68 BAUSCH & LOMB MAJOR PRODUCT OFFERINGS
TABLE 69 THE COOPER COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 70 ABB OPTICAL GROUP: MAJOR PRODUCT OFFERINGS
TABLE 71 ACCULENS: MAJOR PRODUCT OFFERINGS
TABLE 72 ADVANCED VISION TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 73 CONTAMAC: MAJOR PRODUCT OFFERINGS
TABLE 74 EXCELLENT HI-CARE: MAJOR PRODUCT OFFERINGS
TABLE 75 MEDENNIUM: MAJOR PRODUCT OFFERINGS
TABLE 76 MENICON: MAJOR PRODUCT OFFERINGS
TABLE 77 METRO OPTICS: MAJOR PRODUCT OFFERINGS
TABLE 78 ORION VISION GROUP: MAJOR PRODUCT OFFERINGS
TABLE 79 POLYTOUCH: MAJOR PRODUCT OFFERINGS
TABLE 80 ST. SHINE OPTICAL: MAJOR PRODUCT OFFERINGS
TABLE 81 SURGITECH INNOVATION: MAJOR PRODUCT OFFERINGS
TABLE 82 SYNERGEYES: MAJOR PRODUCT OFFERINGS
TABLE 83 ULTRAVISION CLPL: MAJOR PRODUCT OFFERINGS
TABLE 84 WALMAN: MAJOR PRODUCT OFFERINGS
TABLE 85 VISIONARY OPTICS: MAJOR PRODUCT OFFERINGS
TABLE 86 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 87 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 88 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 89 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 90 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 91 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 92 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 93 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 94 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 95 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 96 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 97 NORTH AMERICA CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 98 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 99 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 100 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 101 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 102 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 103 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 104 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 105 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 106 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 107 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 108 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 109 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 110 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 111 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 112 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 113 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 114 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 115 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 116 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 117 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 118 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 119 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 120 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 121 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 122 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 123 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 124 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 125 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 126 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 127 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
TABLE 128 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 129 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021–2027 (%)
TABLE 130 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027 ($ MILLION)
TABLE 131 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021–2027(%)
TABLE 132 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 133 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021–2027 (%)
TABLE 134 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 ($ MILLION)
TABLE 135 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
